Metagenomi, Inc. Common Stock (MGX)
Healthcare
Biotechnology
1.20 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Metagenomi, Inc. Common Stock (MGX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.6% of the shares are freely tradable; institutional investors hold 19.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
19.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
19.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
67.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
38Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 3.37 | 1,270,246 | +2.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.81 | 1,057,944 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 2.09 | 787,900 | +25.4 | 03/31/2026 |
| Catalio Capital Management, LP | 1.41 | 528,993 | +0.0 | 03/31/2026 |
| Peapod Lane Capital LLC | 1.37 | 516,761 | +3.8 | 03/31/2026 |
| Two Sigma Investments LLC | 1.32 | 496,767 | +12.5 | 03/31/2026 |
| Bridgeway Capital Management, LLC | 1.05 | 395,800 | +0.0 | 03/31/2026 |
| Jacobs Levy Equity Management, Inc. | 1.02 | 382,153 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.95 | 358,200 | +17.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.97 | 741,407 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.